Pioneering Intranasal Delivery of mRNA, Antibodies, and Biologics to Unlock New Therapeutic Possibilities

  • New small biologics fit for nasal delivery & biophysical attributes
  • Demonstration of preclinical efficacy of inhaled biological antivirals
  • Impact on mucosal immunity